{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T22:19:30Z","timestamp":1783808370651,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T00:00:00Z","timestamp":1529366400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12957-018-1414-6","type":"journal-article","created":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T21:32:42Z","timestamp":1529357562000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Application of a carbon nanoparticle suspension for sentinel lymph node mapping in patients with early breast cancer: a retrospective cohort study"],"prefix":"10.1186","volume":"16","author":[{"given":"Liulu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciqiu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongfei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minyi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,19]]},"reference":[{"key":"1414_CR1","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1002\/1097-0142(19831101)52:9<1551::AID-CNCR2820520902>3.0.CO;2-3","volume":"52","author":"B Fisher","year":"1983","unstructured":"Fisher B, Bauer M, Wickerham DL, Redmond CK, Fisher ER, Cruz AB, et al. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update. Cancer. 1983;52:1551\u20137.","journal-title":"Cancer"},{"key":"1414_CR2","doi-asserted-by":"publisher","first-page":"7703","DOI":"10.1200\/JCO.2005.08.001","volume":"23","author":"GH Lyman","year":"2005","unstructured":"Lyman GH, Giuliano AE, Somerfield MR, Benson AB 3rd, Bodurka DC, Burstein HJ, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005;23:7703\u201320.","journal-title":"J Clin Oncol"},{"key":"1414_CR3","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","volume":"11","author":"DN Krag","year":"2010","unstructured":"Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11:927\u201333.","journal-title":"Lancet Oncol"},{"key":"1414_CR4","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/jnci\/djj158","volume":"98","author":"RE Mansel","year":"2006","unstructured":"Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial. J Natl Cancer Inst. 2006;98:599\u2013609.","journal-title":"J Natl Cancer Inst"},{"key":"1414_CR5","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1001\/jama.1996.03540220042028","volume":"276","author":"JJ Albertini","year":"1996","unstructured":"Albertini JJ, Lyman GH, Cox C, Yeatman T, Balducci L, Ku N, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA. 1996;276:1818\u201322.","journal-title":"JAMA"},{"key":"1414_CR6","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1245\/s10434-007-9418-4","volume":"14","author":"L Wang","year":"2007","unstructured":"Wang L, Yu JM, Wang YS, Zuo WS, Gao Y, Fan J, et al. Preoperative lymphoscintigraphy predicts the successful identification but is not necessary in sentinel lymph nodes biopsy in breast cancer. Ann Surg Oncol. 2007;14:2215\u201320.","journal-title":"Ann Surg Oncol"},{"key":"1414_CR7","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s10549-006-9192-1","volume":"99","author":"A Goyal","year":"2006","unstructured":"Goyal A, Newcombe RG, Chhabra A, Mansel RE, ALMANAC Trialists Group. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer\u2014results of the ALMANAC validation phase. Breast Cancer Res Treat. 2006;99:203\u20138.","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"1414_CR8","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","volume":"11","author":"DN Krag","year":"2010","unstructured":"Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11(10):927\u201333.","journal-title":"Lancet Oncol"},{"key":"1414_CR9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/cncr.21568","volume":"106","author":"T Kim","year":"2006","unstructured":"Kim T, Giuliano AE, Lyman GH. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a meta-analysis. Cancer. 2006;106:4\u201316.","journal-title":"Cancer"},{"key":"1414_CR10","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1245\/s10434-010-0945-z","volume":"17","author":"ME Straver","year":"2010","unstructured":"Straver ME, Meijnen P, van Tienhoven G, van de Velde CJ, Mansel RE, Bogaerts J, et al. Sentinel node identification rate and nodal involvement in the EORTC 10981-22023 AMAROS trial. Ann Surg Oncol. 2010;17:1854\u201361.","journal-title":"Ann Surg Oncol"},{"key":"1414_CR11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/SLA.0b013e31812e6a73","volume":"247","author":"G Zavagno","year":"2008","unstructured":"Zavagno G, De Salvo GL, Scalco G, Bozza F, Barutta L, Del Bianco P, et al. A randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella\/GIVOM trial. Ann Surg. 2008;247:207\u201313.","journal-title":"Ann Surg"},{"key":"1414_CR12","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/S0002-9610(99)00230-5","volume":"178","author":"SL Stratmann","year":"1999","unstructured":"Stratmann SL, McCarty TM, Kuhn JA. Radiation safety with breast sentinel node biopsy. Am J Surg. 1999;178:454\u20137.","journal-title":"Am J Surg"},{"key":"1414_CR13","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.amjsurg.2007.08.060","volume":"196","author":"S Zakaria","year":"2008","unstructured":"Zakaria S, Hoskin TL, Degnim AC. Safety and technical success of methylene blue dye for lymphatic mapping in breast cancer. Am J Surg. 2008;196:228\u201333.","journal-title":"Am J Surg"},{"key":"1414_CR14","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.ejso.2004.12.009","volume":"31","author":"GA Govaert","year":"2005","unstructured":"Govaert GA, Oostenbroek RJ, Plaisier PW. Prolonged skin staining after intradermal use of patent blue in sentinel lymph node biopsy for breast cancer. Eur J Surg Oncol. 2005;31:373\u20135.","journal-title":"Eur J Surg Oncol"},{"key":"1414_CR15","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/S0002-9610(02)00945-5","volume":"184","author":"B Stradling","year":"2002","unstructured":"Stradling B, Aranha G, Gabram S. Adverse skin lesions after methylene blue injections for sentinel lymph node localization. Am J Surg. 2002;184:350\u20132.","journal-title":"Am J Surg"},{"key":"1414_CR16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1524-4741.2007.00519.x","volume":"14","author":"P Varghese","year":"2008","unstructured":"Varghese P, Abdel-Rahman AT, Akberali S, Mostafa A, Gattuso JM, Carpenter R. Methylene blue dye\u2014a safe and effective alternative for sentinel lymph node localization. Breast J. 2008;14:61\u20137.","journal-title":"Breast J"},{"key":"1414_CR17","doi-asserted-by":"publisher","first-page":"e351","DOI":"10.1016\/S1470-2045(13)70590-4","volume":"15","author":"M Ahmed","year":"2014","unstructured":"Ahmed M, Purushotham AD, Douek M. Novel techniques for sentinel lymph node biopsy in breast cancer: a systematic review. Lancet Oncol. 2014;15:e351\u201362.","journal-title":"Lancet Oncol"},{"key":"1414_CR18","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.3390\/ijms18122562","volume":"18","author":"P Xie","year":"2017","unstructured":"Xie P, Yang ST, He T, Yang S, Tang XH. Bioaccumulation and toxicity of carbon nanoparticles suspension injection in intravenously exposed mice. Int J Mol Sci. 2017;18:2562.","journal-title":"Int J Mol Sci"},{"key":"1414_CR19","doi-asserted-by":"publisher","first-page":"5585","DOI":"10.2147\/OTT.S146627","volume":"10","author":"LY Wang","year":"2017","unstructured":"Wang LY, Li JH, Zhou X, Zheng QC, Cheng X. Clinical application of carbon nanoparticles in curative resection for colorectal carcinoma. Onco Targets Ther. 2017;10:5585\u20139.","journal-title":"Onco Targets Ther"},{"key":"1414_CR20","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12957-016-0835-3","volume":"14","author":"Z Li","year":"2016","unstructured":"Li Z, Ao S, Bu Z, Wu A, Wu X, Shan F, et al. Clinical study of harvesting lymph nodes with carbon nanoparticles in advanced gastric cancer: a prospective randomized trial. World J Surg Oncol. 2016;14:88.","journal-title":"World J Surg Oncol"},{"key":"1414_CR21","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006285","volume":"96","author":"WJ Zhao","year":"2017","unstructured":"Zhao WJ, Luo H, Zhou YM, Gou ZH, Wang B, Zhu JQ. Preoperative ultrasound-guided carbon nanoparticles localization for metastatic lymph nodes in papillary thyroid carcinoma during reoperation: a retrospective cohort study. Medicine (Baltimore). 2017;96:e6285.","journal-title":"Medicine (Baltimore)"},{"key":"1414_CR22","doi-asserted-by":"publisher","first-page":"e351","DOI":"10.1016\/S1470-2045(13)70590-4","volume":"15","author":"M Ahmed","year":"2014","unstructured":"Ahmed M, Purushotham AD, Donek M. Novel techniques for sentinel lymph node biopsy in breast cancer: a systematic review. Lancet Oncol. 2014;15:e351\u201362.","journal-title":"Lancet Oncol"},{"key":"1414_CR23","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1075-122X.2006.00299.x","volume":"12","author":"M Golshan","year":"2006","unstructured":"Golshan M, Nakhlis F. Can methylene blue only be used in sentinel lymph node biopsy for breast cancer? Breast J. 2006;12:428\u201330.","journal-title":"Breast J"},{"key":"1414_CR24","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1245\/s10434-015-4809-4","volume":"23","author":"T Sugie","year":"2016","unstructured":"Sugie T, Kinoshita T, Masuda N, Sawada T, Yamauchi A, Kuroi K, et al. Evaluation of the clinical utility of the ICG fluorescence method compared with the radioisotope method for sentinel lymph node biopsy in breast cancer. Ann Surg Oncol. 2016;23:44\u201350.","journal-title":"Ann Surg Oncol"},{"key":"1414_CR25","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1002\/bjs.10283","volume":"103","author":"A Zada","year":"2016","unstructured":"Zada A, Peek MC, Ahmed M, Anninga B, Baker R, Kusakabe M, et al. Meta-analysis of sentinel lymph node biopsy in breast cancer using the magnetic technique. Br J Surg. 2016;103:1409\u201319.","journal-title":"Br J Surg"},{"key":"1414_CR26","doi-asserted-by":"publisher","first-page":"e0135714","DOI":"10.1371\/journal.pone.0135714","volume":"10","author":"X Wu","year":"2015","unstructured":"Wu X, Lin Q, Chen G, Lu J, Zeng Y, Chen X, et al. Sentinel lymph node detection using carbon nanoparticles in patients with early breast cancer. PLoS One. 2015;10:e0135714.","journal-title":"PLoS One"},{"key":"1414_CR27","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ejso.2014.11.004","volume":"41","author":"C Bonneau","year":"2015","unstructured":"Bonneau C, Bendifallah S, Reyal F, Rossi L, Rouzier R. Association of the number of sentinel lymph nodes harvested with survival in breast cancer. Eur J Surg Oncol. 2015;41:52\u20138.","journal-title":"Eur J Surg Oncol"},{"key":"1414_CR28","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1002\/bjs.4906","volume":"92","author":"A Goyal","year":"2005","unstructured":"Goyal A, Newcombe RG, Mansell RE. Clinical relevance of multiple sentinelnodes in patients with breast cancer. Br J Surg. 2005;92:438\u201342.","journal-title":"Br J Surg"},{"key":"1414_CR29","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S0002-9610(01)00734-6","volume":"182","author":"D Albo","year":"2001","unstructured":"Albo D, Wayne JD, Hunt KK, Rahlfs TF, Singletary SE, Ames FC, et al. Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer. Am J Sur. 2001;182:393\u20138.","journal-title":"Am J Sur"},{"key":"1414_CR30","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.amjsurg.2004.06.042","volume":"189","author":"S Thevarajah","year":"2005","unstructured":"Thevarajah S, Huston TL, Simmons RM. A comparison of the adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer. Am J Surg. 2005;189:236\u20139.","journal-title":"Am J Surg"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-018-1414-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12957-018-1414-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-018-1414-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T19:23:43Z","timestamp":1560885823000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-018-1414-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,19]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1414"],"URL":"https:\/\/doi.org\/10.1186\/s12957-018-1414-6","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,19]]},"assertion":[{"value":"28 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Ethics Committee of Guangdong General Hospital approved the study. The informed consent was waived because this is a retrospective study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"112"}}